|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.13 USD | -1.12% |
|
-11.78% | -8.22% |
| 07-13 | Stoke Therapeutics Announces Appointment of Thomas McCauley as Chief Scientific Officer | CI |
| 07-13 | Goldman Sachs Initiates Coverage on Stoke Therapeutics With Buy Rating, $44 Price Target | MT |
| Market Cap | 1.81B 1.59B 1.47B 1.35B 2.55B 174B 2.6B 17.48B 6.86B 85.33B 6.81B 6.66B 294B | P/E 2026 * |
-8.86x | P/E 2027 * | -9.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.62B 1.42B 1.31B 1.21B 2.28B 156B 2.32B 15.61B 6.12B 76.19B 6.08B 5.95B 262B | EV / Sales 2026 * |
66.6x | EV / Sales 2027 * | 33.5x |
| Free-Float |
96.18% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Stoke Therapeutics, Inc.
| 1 day | -1.12% | ||
| 1 week | -11.78% | ||
| Current month | -10.97% | ||
| 1 month | -2.31% | ||
| 3 months | -18.77% | ||
| 6 months | -5.94% | ||
| Current year | -8.22% |
| 1 week | 28.71 |  | 33.4 |
| 1 month | 28.71 | | 33.72 |
| Current year | 25.21 | | 40.22 |
| 1 year | 11.69 | | 40.22 |
| 3 years | 3.35 | | 40.22 |
| 5 years | 3.35 | | 40.22 |
| 10 years | 3.35 | | 71.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ian Smith
CEO | Chief Executive Officer | 60 | 2025-03-18 |
Isabel Aznarez
CTO | Chief Tech/Sci/R&D Officer | 54 | 2014-05-31 |
Thomas Leggett
DFI | Director of Finance/CFO | 49 | 2024-05-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Seth Harrison
CHM | Chairman | 65 | 2015-06-30 |
Adrian Krainer
BRD | Director/Board Member | 67 | 2014-05-31 |
Arthur Levin
BRD | Director/Board Member | 72 | 2015-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-30 | Sell | Chief Technology Officer | -7,228 | 0.0122% | ||
| 06-15 | Sell | General Counsel | -1,457 | 0.0023% | ||
| 06-02 | Free | Director | 17,786 | 0.0286% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.12% | -11.78% | +141.54% | +187.00% | 1.81B | |
| -0.21% | +1.36% | +3.05% | +7.32% | 50.35B | |
| +0.55% | -2.88% | +382.07% | +593.81% | 39.32B | |
| +0.13% | -0.19% | +29.79% | -6.00% | 34.69B | |
| +0.86% | -0.78% | +21.58% | +56.15% | 34.08B | |
| -1.31% | -3.03% | +2.51% | +25.24% | 26.63B | |
| +0.13% | -0.52% | - | - | 16.49B | |
| +1.13% | -1.85% | +67.36% | +120.46% | 15.31B | |
| +0.23% | +3.19% | +14.80% | +17.81% | 13.8B | |
| +1.13% | -0.44% | +12.34% | -31.79% | 12.87B | |
| Average | +0.16% | -1.92% | +75.01% | +107.78% | 24.54B | |
| Weighted average by Cap. | +0.19% | -0.81% | +81.56% | +122.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 24.32M 21.25M 19.65M 18.15M 34.18M 2.34B 34.8M 234M 91.92M 1.14B 91.34M 89.32M 3.94B | 46.5M 40.64M 37.57M 34.71M 65.36M 4.47B 66.55M 448M 176M 2.19B 175M 171M 7.53B |
| Net income | -211M -184M -170M -157M -296M -20.25B -302M -2.03B -797M -9.91B -792M -774M -34.14B | -212M -185M -171M -158M -298M -20.35B -303M -2.04B -801M -9.96B -796M -778M -34.31B |
| Net Debt | -194M -170M -157M -145M -273M -18.67B -278M -1.87B -735M -9.14B -730M -714M -31.48B | -256M -224M -207M -191M -360M -24.6B -367M -2.47B -968M -12.05B -962M -941M -41.48B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-14 | US$29.13 | -1.12% | 560,309 |
| 26-07-13 | US$29.46 | -6.12% | 580,470 |
| 26-07-10 | US$31.38 | -4.42% | 614,856 |
| 26-07-09 | US$32.83 | +0.55% | 493,778 |
| 26-07-08 | US$32.65 | -1.12% | 1,010,902 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- STOK Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
